• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大脑中N-甲基-D-天冬氨酸受体结构域的区域特异性化学计量

Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain.

作者信息

Matsunaga T, Mukhin A G, London E D

机构信息

Neuroimaging and Drug Action Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.

出版信息

Neuroreport. 1996 Feb 29;7(3):833-7. doi: 10.1097/00001756-199602290-00036.

DOI:10.1097/00001756-199602290-00036
PMID:8733756
Abstract

A stoichiometric analysis of N-methyl-D-aspartate (NMDA) receptor binding was conducted using [3H]dizocilpine, [3H]dichlorokynurenic acid and [3H]CGP39653, and membranes from various brain regions of rats. The ratio of the density of [3H]CGP39653 binding to [3H]dizocilpine binding was > 1 in frontal cortex and hippocampus, approximately 1 in striatum and spinal cord and < 1 in cerebellum. When [3H]dichlorokynurenic acid binding was compared with [3H]dizocilpine binding, the ratios were > 1 in frontal cortex, hippocampus and striatum, 3-4 in cerebellum, and approximately 2 in spinal cord. These observations suggest that a single channel complex may have more than one binding site for NMDA and/or glycine and that the stoichiometry between the binding domains of the NMDA receptor varies regionally.

摘要

使用[3H]地佐环平、[3H]二氯喹啉酸和[3H]CGP39653以及来自大鼠不同脑区的膜进行了N-甲基-D-天冬氨酸(NMDA)受体结合的化学计量分析。[3H]CGP39653与[3H]地佐环平结合密度的比值在额叶皮质和海马中>1,在纹状体和脊髓中约为1,在小脑中<1。当比较[3H]二氯喹啉酸与[3H]地佐环平结合时,该比值在额叶皮质、海马和纹状体中>1,在小脑中为3 - 4,在脊髓中约为2。这些观察结果表明,单个通道复合物可能对NMDA和/或甘氨酸有多个结合位点,并且NMDA受体结合域之间的化学计量在不同区域有所变化。

相似文献

1
Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain.大脑中N-甲基-D-天冬氨酸受体结构域的区域特异性化学计量
Neuroreport. 1996 Feb 29;7(3):833-7. doi: 10.1097/00001756-199602290-00036.
2
Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.通过N-甲基-D-天冬氨酸受体的甘氨酸位点对[3H]-CGP39653结合的变构调节:大鼠和人脑中的进一步研究
Br J Pharmacol. 2001 Apr;132(8):1883-97. doi: 10.1038/sj.bjp.0704017.
3
Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.通过配体结合以及大鼠脑中[3H]-CGP 39653的定量放射自显影区分区域不同的N-甲基-D-天冬氨酸受体
Br J Pharmacol. 1996 Nov;119(5):819-28. doi: 10.1111/j.1476-5381.1996.tb15746.x.
4
In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.SM-31900对NMDA受体甘氨酸结合位点的体外和体内拮抗活性。
Brain Res. 2002 Jul 19;944(1-2):165-73. doi: 10.1016/s0006-8993(02)02741-5.
5
N-methyl-D-aspartate receptor binding in brains of rats at different ages.
Neurobiol Aging. 1997 May-Jun;18(3):329-33. doi: 10.1016/s0197-4580(97)80315-6.
6
Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.多胺对N-甲基-D-天冬氨酸受体功能的影响:谷氨酸和甘氨酸位点拮抗剂的差异改变
Brain Res. 1991 Oct 11;561(2):285-91. doi: 10.1016/0006-8993(91)91606-2.
7
N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.在怀孕大鼠中,N-甲基-D-天冬氨酸受体结合发生改变,癫痫发作可能性降低。
Brain Res. 1999 Oct 9;844(1-2):10-9. doi: 10.1016/s0006-8993(99)01798-9.
8
Pharmacological characterization of N-methyl-D-aspartate receptors in spinal cord of rats with a chronic peripheral mononeuropathy.
Neuropharmacology. 1997 Nov-Dec;36(11-12):1561-9. doi: 10.1016/s0028-3908(97)00146-9.
9
Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims.自杀受害者额叶皮质中N-甲基-D-天冬氨酸(NMDA)受体复合物的改变。
Brain Res. 1995 Mar 27;675(1-2):157-64. doi: 10.1016/0006-8993(95)00057-w.
10
Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
Eur J Pharmacol. 1994 Jan 1;266(1):103-6. doi: 10.1016/0922-4106(94)90215-1.